PortalPublikationenDiagnostik und Therapie von Tuberkulose unter Immuntherapien...

Diagnostik und Therapie von Tuberkulose unter Immuntherapien für Multiple Sklerose: Aktueller Stand und Empfehlungen in Deutschland

Standard

Diagnostik und Therapie von Tuberkulose unter Immuntherapien für Multiple Sklerose: Aktueller Stand und Empfehlungen in Deutschland. / Bittner, Stefan; Engel, Sinah; Lange, Christoph; Weber, Martin S; Haghikia, Aiden; Luessi, Felix; Korn, Thomas; Klotz, Luisa; Bayas, Antonios; Paul, Friedemann; Heesen, Christoph; Stangel, Martin; Wildemann, Brigitte; Bergh, Florian Then; Tackenberg, Björn; Trebst, Corinna; Warnke, Clemens; Linker, Ralf; Kerschensteiner, Martin; Zettl, Uwe; Tumani, Hayrettin; Brück, Wolfgang; Meuth, Sven G; Kümpfel, Tanja; Hemmer, Bernhard; Wiendl, Heinz; Gold, Ralf; Zipp, Frauke.

in: NERVENARZT, Jahrgang 90, Nr. 12, 12.2019, S. 1245-1253.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung

Harvard

Bittner, S, Engel, S, Lange, C, Weber, MS, Haghikia, A, Luessi, F, Korn, T, Klotz, L, Bayas, A, Paul, F, Heesen, C, Stangel, M, Wildemann, B, Bergh, FT, Tackenberg, B, Trebst, C, Warnke, C, Linker, R, Kerschensteiner, M, Zettl, U, Tumani, H, Brück, W, Meuth, SG, Kümpfel, T, Hemmer, B, Wiendl, H, Gold, R & Zipp, F 2019, 'Diagnostik und Therapie von Tuberkulose unter Immuntherapien für Multiple Sklerose: Aktueller Stand und Empfehlungen in Deutschland', NERVENARZT, Jg. 90, Nr. 12, S. 1245-1253. https://doi.org/10.1007/s00115-019-0760-0

APA

Bittner, S., Engel, S., Lange, C., Weber, M. S., Haghikia, A., Luessi, F., Korn, T., Klotz, L., Bayas, A., Paul, F., Heesen, C., Stangel, M., Wildemann, B., Bergh, F. T., Tackenberg, B., Trebst, C., Warnke, C., Linker, R., Kerschensteiner, M., ... Zipp, F. (2019). Diagnostik und Therapie von Tuberkulose unter Immuntherapien für Multiple Sklerose: Aktueller Stand und Empfehlungen in Deutschland. NERVENARZT, 90(12), 1245-1253. https://doi.org/10.1007/s00115-019-0760-0

Vancouver

Bittner S, Engel S, Lange C, Weber MS, Haghikia A, Luessi F et al. Diagnostik und Therapie von Tuberkulose unter Immuntherapien für Multiple Sklerose: Aktueller Stand und Empfehlungen in Deutschland. NERVENARZT. 2019 Dez;90(12):1245-1253. https://doi.org/10.1007/s00115-019-0760-0

Bibtex

@article{07bce89b49974399a7b16c05d4ff1fad,
title = "Diagnostik und Therapie von Tuberkulose unter Immuntherapien f{\"u}r Multiple Sklerose: Aktueller Stand und Empfehlungen in Deutschland",
abstract = "After years of low incidence, a large increase of new tuberculosis (TB) cases has been reported in Germany since 2015. New immunotherapies for the treatment of multiple sclerosis (MS) are associated with a reduced immune competence and a potential increased risk for infections. Most neurologists lack specific experiences with TB infections. This article summarizes specific recommendations for the diagnostics and treatment of TB under MS immunotherapies with a focus on the situation in Germany. Due to low case numbers and little experience with the risk of TB under the new immunotherapies, the clinical competence network for MS (KKNMS) consensus recommendations have a low grade of evidence.",
author = "Stefan Bittner and Sinah Engel and Christoph Lange and Weber, {Martin S} and Aiden Haghikia and Felix Luessi and Thomas Korn and Luisa Klotz and Antonios Bayas and Friedemann Paul and Christoph Heesen and Martin Stangel and Brigitte Wildemann and Bergh, {Florian Then} and Bj{\"o}rn Tackenberg and Corinna Trebst and Clemens Warnke and Ralf Linker and Martin Kerschensteiner and Uwe Zettl and Hayrettin Tumani and Wolfgang Br{\"u}ck and Meuth, {Sven G} and Tanja K{\"u}mpfel and Bernhard Hemmer and Heinz Wiendl and Ralf Gold and Frauke Zipp",
year = "2019",
month = dec,
doi = "10.1007/s00115-019-0760-0",
language = "Deutsch",
volume = "90",
pages = "1245--1253",
journal = "NERVENARZT",
issn = "0028-2804",
publisher = "Springer",
number = "12",

}

RIS

TY - JOUR

T1 - Diagnostik und Therapie von Tuberkulose unter Immuntherapien für Multiple Sklerose: Aktueller Stand und Empfehlungen in Deutschland

AU - Bittner, Stefan

AU - Engel, Sinah

AU - Lange, Christoph

AU - Weber, Martin S

AU - Haghikia, Aiden

AU - Luessi, Felix

AU - Korn, Thomas

AU - Klotz, Luisa

AU - Bayas, Antonios

AU - Paul, Friedemann

AU - Heesen, Christoph

AU - Stangel, Martin

AU - Wildemann, Brigitte

AU - Bergh, Florian Then

AU - Tackenberg, Björn

AU - Trebst, Corinna

AU - Warnke, Clemens

AU - Linker, Ralf

AU - Kerschensteiner, Martin

AU - Zettl, Uwe

AU - Tumani, Hayrettin

AU - Brück, Wolfgang

AU - Meuth, Sven G

AU - Kümpfel, Tanja

AU - Hemmer, Bernhard

AU - Wiendl, Heinz

AU - Gold, Ralf

AU - Zipp, Frauke

PY - 2019/12

Y1 - 2019/12

N2 - After years of low incidence, a large increase of new tuberculosis (TB) cases has been reported in Germany since 2015. New immunotherapies for the treatment of multiple sclerosis (MS) are associated with a reduced immune competence and a potential increased risk for infections. Most neurologists lack specific experiences with TB infections. This article summarizes specific recommendations for the diagnostics and treatment of TB under MS immunotherapies with a focus on the situation in Germany. Due to low case numbers and little experience with the risk of TB under the new immunotherapies, the clinical competence network for MS (KKNMS) consensus recommendations have a low grade of evidence.

AB - After years of low incidence, a large increase of new tuberculosis (TB) cases has been reported in Germany since 2015. New immunotherapies for the treatment of multiple sclerosis (MS) are associated with a reduced immune competence and a potential increased risk for infections. Most neurologists lack specific experiences with TB infections. This article summarizes specific recommendations for the diagnostics and treatment of TB under MS immunotherapies with a focus on the situation in Germany. Due to low case numbers and little experience with the risk of TB under the new immunotherapies, the clinical competence network for MS (KKNMS) consensus recommendations have a low grade of evidence.

U2 - 10.1007/s00115-019-0760-0

DO - 10.1007/s00115-019-0760-0

M3 - SCORING: Review

C2 - 31297574

VL - 90

SP - 1245

EP - 1253

JO - NERVENARZT

JF - NERVENARZT

SN - 0028-2804

IS - 12

ER -